Astrana Health (ASTH) Cash from Financing Activities (2011 - 2026)

Astrana Health has reported Cash from Financing Activities for 16 years, with the latest figure at -$16.0 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 63.87% year-over-year to -$16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $597.6 million (up 3986.54% YoY) and the FY2025 annual result came in at $569.3 million, up 321.28% from the prior year.
• Cash from Financing Activities advanced to -$16.0 million in Q1 2026 per ASTH's latest filing, from -$26.3 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $648.5 million in Q3 2025 and troughed at -$44.2 million in Q1 2025.
• A 5-year average of $39.5 million and a median of -$3.2 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities tumbled 1434.4% in 2023, then jumped 20428.87% in 2025.
• Over 5 years, Cash from Financing Activities stood at $5.9 million in 2022, then surged by 104.28% to $12.0 million in 2023, then slumped by 227.3% to -$15.3 million in 2024, then plunged by 72.51% to -$26.3 million in 2025, then jumped by 39.4% to -$16.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$16.0 million, -$26.3 million, and $648.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.